| Abbott profit tops forecast; drugs, devices shine |
| Reuters - 16 Jul 14:20 |
| Abbott profit rises on sales of drugs, devices |
| Reuters - 16 Apr 14:20 |
| OncoMethylome sluit dienstenovereenkomst met Abbott |
| Eurobench - 17 Dec 08:40 |
| Abbott verhoogt onderkant winstverwachting 2007 |
| Eurobench - 17 Oct 15:01 |
| Abbott vernauwt winstverwachting 2007 |
| Eurobench - 18 Jul 14:20 |
| GE en Abbott zien af van overnametransactie |
| Belegger.nl - 12 Jul 12:00 |
| GE, Abbott end $8 bln deal for diagnostics business |
| Reuters - 12 Jul 06:00 |
| Abbott seeks FDA OK of drug-eluting stent |
| Reuters - 1 Jun 19:20 |
| EU clears GE's buy of two Abbott diagnostics units |
| Reuters - 25 Apr 10:40 |
| Crucell tekent licentie-overeenkomst met Abbott |
| Eurobench - 31 Jan 09:00 |
| Innogenetics eist hogere vergoeding in rechtszaak tegen Abbott |
| Belegger.nl - 25 Jan 09:18 |
| Abbott posts loss on Kos purchase |
| Reuters - 24 Jan 15:36 |
| Abbott posts loss on Kos purchase |
| Reuters - 24 Jan 14:43 |
| Abbott boekt in 4ekw '06 winst ex-items boven marktconsensus |
| Eurobench - 24 Jan 14:24 |
| GE koopt deel diagnostiekactiviteiten Abbott |
| Belegger.nl - 19 Jan 10:30 |
| GE koopt diagnostiekactiviteiten van Abbott voor USD 8,1 mrd |
| Eurobench - 19 Jan 07:30 |
| GE to buy Abbott diagnostics units for $8.13 billion |
| Reuters - 18 Jan 23:41 |
| GE to buy Abbott diagnostics units for $8.13 billion |
| Reuters - 18 Jan 23:05 |
| General Electric to pay $8.13 billion for Abbott units |
| Reuters - 18 Jan 22:30 |
| Abbott to keep at least 2 diagnostics units: source |
| Reuters - 18 Jan 18:18 |
| GE near deal to buy Abbott diagnostics unit: reports |
| Reuters - 18 Jan 13:18 |
| Innogenetics says U.S. court upholds Abbott damages |
| Reuters - 4 Jan 09:18 |
| Abbott to buy Kos, become HDL-cholesterol leader |
| Reuters - 6 Nov 18:24 |
| Abbott to buy Kos for $3.7 bln in cholesterol move |
| Reuters - 6 Nov 16:00 |
| Abbott to buy Kos for $3.7 bln in cholesterol move |
| Reuters - 6 Nov 15:36 |
| Abbott neemt cholesterol-specialist over |
| Belegger.nl - 6 Nov 15:36 |
| Abbott to buy Kos for $3.7 bln in cholesterol move |
| Reuters - 6 Nov 15:12 |
| Abbott neemt cholestrol-specialist over |
| Belegger.nl - 6 Nov 15:12 |
| Abbott neemt Kos Pharmaceuticals over voor USD 3,7 miljard |
| Eurobench - 6 Nov 14:48 |
| Abbott to buy Kos for $3.7 bln in cholesterol move |
| Reuters - 6 Nov 14:24 |
| Abbott profit rises on soaring Humira sales |
| Reuters - 18 Oct 16:24 |
| Abbott profit rises on soaring Humira sales |
| Reuters - 18 Oct 14:48 |
| J&J sues Boston Scientific, Abbott for $5.5 bln |
| Reuters - 26 Sep 19:36 |
| J&J sues Boston Scientific, Abbott for $5.5 bln |
| Reuters - 26 Sep 18:29 |
| Abbott employee class action can proceed: judge |
| Reuters - 18 Aug 22:20 |
| Abbott quarterly profit beats Street; outlook raised |
| Reuters - 19 Jul 17:19 |
| Abbott quarterly profit beats Street; outlook raised |
| Reuters - 19 Jul 15:59 |
| Abbott profit falls on Guidant costs |
| Reuters - 19 Jul 14:00 |
| US joins lawsuit against Abbott on drug prices |
| Reuters - 18 May 23:08 |
| US joins lawsuit against Abbott on drug prices |
| Reuters - 18 May 21:40 |
| Abbott sees Guidant buy dilutive in '06 |
| Reuters - 21 Apr 19:00 |
| Abbott sees Guidant products boosting its profit |
| Reuters - 21 Apr 14:42 |
| Abbott quarterly net up as it ends distribution deal |
| Reuters - 19 Apr 15:54 |
| Abbott quarterly profit rises on higher gross margins |
| Reuters - 19 Apr 15:01 |
| Abbott quarterly profit rises on higher gross margins |
| Reuters - 19 Apr 14:30 |
| Abbott quarterly profit rises on higher gross margins |
| Reuters - 19 Apr 14:19 |
| Affymetrix, Abbott enter licensing pact |
| Reuters - 5 Apr 14:30 |
| Abbott gets FDA OK to sell new blood glucose monitor |
| Reuters - 13 Mar 14:36 |
| Abbott quarterly profit rises slightly |
| Reuters - 25 Jan 15:42 |
| Abbott quarterly profit rises slightly |
| Reuters - 25 Jan 15:12 |
| Abbott quarterly profit rises slightly |
| Reuters - 25 Jan 14:48 |
| Abbott role in Guidant bid seen as devices play |
| Reuters - 18 Jan 23:06 |
| Abbott role in Guidant bid seen as devices play |
| Reuters - 18 Jan 22:18 |
| Abbott to win big if Boston buys Guidant: analysts |
| Reuters - 10 Jan 11:48 |
| Abbott to win big if Boston buys Guidant: analysts |
| Reuters - 9 Jan 22:54 |
| Abbott Labs sees low-double-digit growth in 2007 |
| Reuters - 15 Dec 18:30 |
| Stocks end flat, as Abbott offsets deals |
| Reuters - 15 Nov 06:20 |
| Stocks end flat as Abbott trims gains |
| Reuters - 14 Nov 23:20 |
| Stocks flat as Abbott offsets M&A deals |
| Reuters - 14 Nov 21:40 |
| Stocks flat as Abbott news offsets gains |
| Reuters - 14 Nov 20:40 |
| Abbott profit falls on charges |
| Reuters - 19 Oct 13:40 |
| Abbott: Escalating profit growth in '07 |
| Reuters - 14 Sep 07:05 |
| Abbott profit rises, but forecast weak |
| Reuters - 13 Jul 22:54 |
| Abbott profit rises, outlook weak |
| Reuters - 13 Jul 22:14 |
| Abbott profit lifted by arthritis drugs |
| Reuters - 13 Jul 18:14 |
| Abbott profit lifted by arthritis drugs |
| Reuters - 13 Jul 16:34 |
| Abbott profit lifted by arthritis drugs |
| Reuters - 13 Jul 14:24 |
| Abbott profit lifted by arthritis drugs |
| Reuters - 13 Jul 13:34 |
Wie brengt u deze website? Dirk Dijksma's profile